| 1 | [SID123091375] | Active | IC50 | 1.5 | Antmicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay [AID522805, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay | | AID | 522805 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 2 | [SID123091375] | Active | IC50 | 3.7 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay [AID522813, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 3.7 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay | | AID | 522813 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 3 | [SID123091375] | Active | IC50 | 4.6 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay [AID522811, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 4.6 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay | | AID | 522811 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 4 | [SID123091375] | Active | IC50 | 7.4 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay [AID522807, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 7.4 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay | | AID | 522807 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 5 | [SID123091375] | Active | IC50 | 9.3 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay [AID522812, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 9.3 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay | | AID | 522812 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 6 | [SID123091375] | Active | IC50 | 12 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay [AID522815, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 12 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay | | AID | 522815 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 7 | [SID123091375] | Active | IC50 | 15.2 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay [AID522809, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 15.2 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay | | AID | 522809 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 8 | [SID123091375] | Active | IC50 | 15.7 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay [AID522808, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 15.7 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay | | AID | 522808 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 9 | [SID123091375] | Active | IC50 | 18.8 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay [AID522806, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 18.8 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay | | AID | 522806 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 10 | [SID123091375] | Active | IC50 | 21.7 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay [AID522816, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 21.7 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay | | AID | 522816 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 11 | [SID123091375] | Active | IC50 | 22.9 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay [AID522814, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 22.9 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay | | AID | 522814 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 12 | [SID123091375] | Active | IC50 | 27.7 | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay [AID522810, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 123091375 | | CID | 2319 | | Outcome | Active | | IC50 | 27.7 [uM] | | BioAssay | Antmicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay | | AID | 522810 | | BioAssay type | Literature | | Target | | | PubMed | 20145086 | | Data Table |  |
|
| 13 | [SID26753695] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID26747725] | Inactive | Potency | 15.8489 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 15 | [SID26747725] | Inactive | Potency | 15.8489 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 16 | [SID26747725] | Inactive | Potency | 15.8489 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 17 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling [AID588513, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling | | AID | 588513 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 18 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling [AID588513, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling | | AID | 588513 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 19 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling [AID588513, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling | | AID | 588513 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 20 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling [AID588513, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of estrogen receptor alpha signaling | | AID | 588513 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 21 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 22 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 23 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 24 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of estrogen receptor alpha signaling [AID588514, Type: confirmatory] | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of estrogen receptor alpha signaling | | AID | 588514 | | BioAssay type | confirmatory | | Target | estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627] | | PubMed | | | Data Table |  |
|
| 25 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 26 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 27 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 28 | [SID26747725] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 29 | [SID26747725] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 30 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 31 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 32 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 33 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 34 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 35 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 36 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 37 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 38 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 39 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 40 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 41 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 42 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 43 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 44 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 45 | [SID26753695] | Inactive | Potency | | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26753695 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 46 | [SID26747725] | Inactive | Potency | | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus [AID930, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus | | AID | 930 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 47 | [SID26747725] | Inactive | Potency | | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus [AID910, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus | | AID | 910 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 48 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 49 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 50 | [SID26747725] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26747725 | | CID | 2319 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|